Reason’s why Bristol-Myers Squibb Company (BMY) is an asset to your trade with current Target Price of $77.01 – Invest Chronicle

Reason’s why Bristol-Myers Squibb Company (BMY) is an asset to your trade with current Target Price of $77.01

At the end of the latest market close, Bristol-Myers Squibb Company (BMY) was valued at $63.13. In that particular session, Stock kicked-off at the price of $63.47 while reaching the peak value of $63.51 and lowest value recorded on the day was $62.5642. The stock current value is $62.84.Recently in News on September 13, 2021, According to New Multinational Survey, Healthcare Providers Believe Immunotherapy Has Potential to Positively Impact Earlier-Stage Cancer Treatment Landscape Across Tumor Types. Oncologists, surgeons, and specialists surveyed cite long-term survival, prevention of relapse or recurrence and quality of life as most important factors when making treatment decisions before and/or after surgery. You can read further details here

Bristol-Myers Squibb Company had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $69.75 on 08/23/21, with the lowest value was $58.63 for the same time period, recorded on 03/04/21.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Bristol-Myers Squibb Company (BMY) full year performance was 6.53%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bristol-Myers Squibb Company shares are logging -9.91% during the 52-week period from high price, and 10.72% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $56.75 and $69.75.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 8824777 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Bristol-Myers Squibb Company (BMY) recorded performance in the market was 1.31%, having the revenues showcasing -6.61% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 140.63B, as it employees total of 30250 workers.

Bristol-Myers Squibb Company (BMY) in the eye of market guru’s

During the last month, 10 analysts gave the Bristol-Myers Squibb Company a BUY rating, 3 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 66.42, with a change in the price was noted -3.48. In a similar fashion, Bristol-Myers Squibb Company posted a movement of -5.25% for the period of last 100 days, recording 9,138,326 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BMY is recording 1.23 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.15.

>> 7 Top Picks for the Post-Pandemic Economy << 

Bristol-Myers Squibb Company (BMY): Stocks Technical analysis and Trends

Raw Stochastic average of Bristol-Myers Squibb Company in the period of last 50 days is set at 3.84%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 3.84%. In the last 20 days, the company’s Stochastic %K was 2.83% and its Stochastic %D was recorded 6.35%.

If we look into the earlier routines of Bristol-Myers Squibb Company, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 1.31%. Additionally, trading for the stock in the period of the last six months notably improved by 2.36%, alongside a boost of 6.53% for the period of the last 12 months. The shares increased approximately by -4.22% in the 7-day charts and went up by -6.14% in the period of the last 30 days. Common stock shares were lifted by -6.61% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *


More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam